A study to evaluate combination therapy of memantine hydrochloride with donepezil hydrochloride compared with dose escalation of donepezil hydrochloride in the patient with Alzheimer's disease who have treated with donepezil hydrochloride

Trial Profile

A study to evaluate combination therapy of memantine hydrochloride with donepezil hydrochloride compared with dose escalation of donepezil hydrochloride in the patient with Alzheimer's disease who have treated with donepezil hydrochloride

Discontinued
Phase of Trial: Phase II

Latest Information Update: 27 Apr 2017

At a glance

  • Drugs Donepezil (Primary) ; Memantine (Primary)
  • Indications Alzheimer's disease
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Daiichi Sankyo Company
  • Most Recent Events

    • 26 Apr 2017 Status changed from active, no longer recruiting to discontinued.
    • 22 Mar 2017 Status changed from recruiting to active, no longer recruiting.
    • 08 Nov 2016 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top